U.S. market Closed. Opens in 2 days 2 hours 13 minutes

VIGL | Vigil Neuroscience, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue399.00K1.01M345.00KN/A
Gross Profit-399.00K-1.01M-345.00KN/A
Operating Expenses88.87M68.88M42.41M6.29M
Selling, General & Admin27.93M21.44M10.08M1.78M
Research & Development60.93M47.44M32.33M4.51M
Other Operating ExpensesN/A-44.00K-877.00KN/A
Operating Income-88.87M-68.88M-42.41M-6.29M
Other Expenses / Income6.23M579.00K-874.00K-22.25M
Before Tax Income-82.64M-68.31M-43.28M-28.55M
Income Tax ExpensesN/A-579.00K-31.00K-12.58K
Net Income-82.64M-67.73M-43.25M-28.55M
Interest ExpensesN/A-78.00KN/AN/A
Basic Shares Outstanding38.71M31.69M1.53M28.26M
Diluted Shares Outstanding38.71M31.69M1.53M28.26M
EBITDA-88.47M-68.88M-42.41M-6.29M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-82.64M-68.38M-43.28M-28.56M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙